NFE2 anticorps (AA 20-373)

N° du produit ABIN7871867

Cet anticorps Lapin Polyclonal détecte spécifiquement NFE2 dans WB et ELISA. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour NFE2 anticorps (AA 20-373) (ABIN7871867)

Antigène: NFE2 (Nuclear Factor (Erythroid-Derived 2), 45kDa (NFE2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NFE2 est non-conjugé

Application: Western Blotting (WB), ELISA

Détail du produit anti-NFE2 anticorps

Épitope: AA 20-373

Fonction: NFE2 Antibody / Nuclear factor erythroid-derived 2 45 kDa subunit

Purification: Antigen affinity purified

Immunogène: E. coli-derived recombinant human protein (amino acids E20-D373) was used as the immunogen for the NFE2 antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the NFE2 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the NFE2 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur NFE2

Antigène: NFE2 (Nuclear Factor (Erythroid-Derived 2), 45kDa (NFE2))

Autre désignation: NFE2

Sujet: Transcription factor NF-E2 45 kDa subunit is a protein that in humans is encoded by the NFE2 gene. Enables several functions, including WW domain binding activity, identical protein binding activity, and protein N-terminus binding activity. Contributes to cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including labyrinthine layer blood vessel development, negative regulation of bone mineralization, and negative regulation of syncytium formation by plasma membrane fusion. Part of protein-DNA complex.

UniProt: Q16621